Manulife (Manufacturers Life Insurance)’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Sell |
24,926
-975
| -4% | -$10.9K | ﹤0.01% | 2413 |
|
|
2025
Q1 | $118K | Sell |
25,901
-737
| -3% | -$3.37K | ﹤0.01% | 2656 |
|
|
2024
Q4 | $150K | Sell |
26,638
-656
| -2% | -$3.7K | ﹤0.01% | 2718 |
|
|
2024
Q3 | $132K | Sell |
27,294
-811
| -3% | -$3.93K | ﹤0.01% | 2787 |
|
|
2024
Q2 | $137K | Buy |
28,105
+4,759
| +20% | +$23.2K | ﹤0.01% | 2736 |
|
|
2024
Q1 | $310K | Sell |
23,346
-2,329
| -9% | -$30.9K | ﹤0.01% | 2386 |
|
|
2023
Q4 | $358K | Buy |
25,675
+823
| +3% | +$11.5K | ﹤0.01% | 2319 |
|
|
2023
Q3 | $330K | Buy |
24,852
+4,113
| +20% | +$54.5K | ﹤0.01% | 2327 |
|
|
2023
Q2 | $389K | Buy |
20,739
+1,904
| +10% | +$35.7K | ﹤0.01% | 2196 |
|
|
2023
Q1 | $272K | Sell |
18,835
-73
| -0.4% | -$1.05K | ﹤0.01% | 2365 |
|
|
2022
Q4 | $366K | Buy |
18,908
+3,721
| +25% | +$72K | ﹤0.01% | 2179 |
|
|
2022
Q3 | $522K | Sell |
15,187
-255
| -2% | -$8.76K | ﹤0.01% | 1955 |
|
|
2022
Q2 | $236K | Buy |
15,442
+578
| +4% | +$8.83K | ﹤0.01% | 2539 |
|
|
2022
Q1 | $339K | Buy |
14,864
+5,961
| +67% | +$136K | ﹤0.01% | 2439 |
|
|
2021
Q4 | $328 | Buy |
8,903
+474
| +6% | +$17 | ﹤0.01% | 2548 |
|
|
2021
Q3 | $396K | Buy |
+8,429
| New | +$396K | ﹤0.01% | 2458 |
|